Identifying a malignant B-cell lymphoma clone in peripheral blood using immunoglobulin high-throughput sequencing and lineage tree analysis

Meirav Kedmi, Hadas Neuman, Guy Bitansky, Meital Nagar, Gaelle Scheinert-Shenhav, Iris Barshack, Ginette Schiby, Hilla Tabibian-Keissar, Abraham Avigdor, Ramit Mehr

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)e239-e242
JournalInternational Journal of Laboratory Hematology
Volume44
Issue number5
DOIs
StatePublished - Oct 2022

Bibliographical note

Funding Information:
Janssen Pharmaceuticals, Grant/Award Number: Oncology Grant; United States‐Israel Binational Science Foundation, Grant/Award Number: 20130432; Bar‐Ilan University Funding information

Funding Information:
This study was supported by Janssen Oncology Grant (to Meirav Kedmi) and by the US‐Israel Binational Science Foundation (BSF) grant number 20130432 (to Ramit Mehr). Hadas Neuman was supported by a Bar‐Ilan University President's Scholarship.

Funding

Janssen Pharmaceuticals, Grant/Award Number: Oncology Grant; United States‐Israel Binational Science Foundation, Grant/Award Number: 20130432; Bar‐Ilan University Funding information This study was supported by Janssen Oncology Grant (to Meirav Kedmi) and by the US‐Israel Binational Science Foundation (BSF) grant number 20130432 (to Ramit Mehr). Hadas Neuman was supported by a Bar‐Ilan University President's Scholarship.

FundersFunder number
Janssen Oncology
Janssen Pharmaceuticals
United States-Israel Binational Science Foundation20130432

    Cite this